Novartis..Gilead..Celgene..all in the CAR t money making space...new kids coming on the block..german IPO also new CAR technology.
Costs associated with treament up to 1.5 mill..
Who would go into this space.highly competitive and patent attorneys challenging continuously.
Unless u can make it much cheaper.(cel?)
Cymerus seems to have the key to the bargain basement...
CAR t is just one needed use for Cymerus...price tag for juno and kite ( bought by gilead and celgene)..20,000,000,000!!!!!!
Our MC 100 mill..ish..1/200th of the above..one application!
Someone needs to be on this board who knows how to promote..
Our MC is so undervalued not sure whether to laugh or cry...
Something very significant needs to happen soon to our global investor visibility..
Science development excellent.
Capital management..-10
CAR t
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $37.01M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.5¢ | $480 | 2.343K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15128 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 43657 | 1 |
View Market Depth
| Last trade - 15.39pm 02/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |